Skip to main content

Publisher: Wiley-Blackwell

Volume 13, Number 5, May 2011

Pharmacotherapy for overweight/obesity in ethnic minorities and White Caucasians: a systematic review and meta-analysis
pp. 385-393(9)
Authors: Osei-Assibey, G.; Adi, Y.; Kyrou, I.; Kumar, S.; Matyka, K.

Favourites:
ADD

An overview of once-weekly glucagon-like peptide-1 receptor agonists—available efficacy and safety data and perspectives for the future
pp. 394-407(14)
Authors: Madsbad, S.; Kielgast, U.; Asmar, M.; Deacon, C. F.; Torekov, S. S.; Holst, J. J.

Favourites:
ADD

Pulmonary delivery of peptide YY for food intake suppression and reduced body weight gain in rats
pp. 408-417(10)
Authors: Nadkarni, P. P.; Costanzo, R. M.; Sakagami, M.

Favourites:
ADD
Favourites:
ADD

A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes
pp. 426-433(8)
Authors: Barrington, P.; Chien, J. Y.; Showalter, H. D. H.; Schneck, K.; Cui, S.; Tibaldi, F.; Ellis, B.; Hardy, T. A.

Favourites:
ADD

LY2189265, a long-acting glucagon-like peptide-1 analogue, showed a dose-dependent effect on insulin secretion in healthy subjects
pp. 434-438(5)
Authors: Barrington, P.; Chien, J. Y.; Tibaldi, F.; Showalter, H. D. H.; Schneck, K.; Ellis, B.

Favourites:
ADD

Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes—a randomized controlled trial
pp. 439-445(7)
Authors: Esposito, K.; Maiorino, M. I.; Di Palo, C.; Gicchino, M.; Petrizzo, M.; Bellastella, G.; Saccomanno, F.; Giugliano, D.

Favourites:
ADD
Favourites:
ADD

A new, highly selective murine peroxisome proliferator-activated receptor agonist increases responsiveness to thermogenic stimuli and glucose uptake in skeletal muscle in obese mice
pp. 455-464(10)
Authors: Ngala, R. A.; Stocker, C. J.; Roy, A. G.; Hislop, D.; Wargent, E.; Bell, R.; Hassall, D. G.; Harling, J. D.; Billin, A. N.; Willson, T. M.; Arch, J. R. S.; Cawthorne, M. A.

Favourites:
ADD
Favourites:
ADD

In support of an early intensive treatment of type 2 diabetes and not necessarily of early polypharmacy
pp. 474-475(2)
Authors: Czupryniak, L.; Szymańska-Garbacz, E.; Pawłowski, M.; Saryusz-Wolska, M.; Loba, J.

Favourites:
ADD

News and Views
pp. 476-477(2)
Author: Idris, Iskandar

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more